A detailed history of Ubs Group Ag transactions in 23and Me Holding Co. stock. As of the latest transaction made, Ubs Group Ag holds 33,490 shares of ME stock, worth $106,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,490
Previous 244,893 86.32%
Holding current value
$106,163
Previous $95,000 88.42%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.29 - $0.51 $61,306 - $107,815
-211,403 Reduced 86.32%
33,490 $11,000
Q2 2024

Aug 13, 2024

SELL
$0.36 - $0.61 $76,980 - $130,439
-213,836 Reduced 46.61%
244,893 $95,000
Q1 2024

May 13, 2024

BUY
$0.4 - $0.91 $43,686 - $99,387
109,217 Added 31.25%
458,729 $243,000
Q4 2023

Feb 09, 2024

BUY
$0.71 - $0.97 $88,046 - $120,288
124,009 Added 54.99%
349,512 $318,000
Q3 2023

Nov 09, 2023

SELL
$0.96 - $2.01 $547 - $1,145
-570 Reduced 0.25%
225,503 $220,000
Q2 2023

Aug 11, 2023

BUY
$1.59 - $2.29 $231,731 - $333,751
145,743 Added 181.43%
226,073 $395,000
Q1 2023

May 12, 2023

SELL
$2.05 - $2.87 $120,751 - $169,051
-58,903 Reduced 42.31%
80,330 $183,000
Q4 2022

Feb 08, 2023

BUY
$2.06 - $3.47 $154,817 - $260,784
75,154 Added 117.28%
139,233 $300,000
Q3 2022

Nov 10, 2022

BUY
$2.6 - $5.12 $42,741 - $84,167
16,439 Added 34.51%
64,079 $184,000
Q2 2022

Aug 10, 2022

SELL
$2.19 - $3.98 $19,773 - $35,935
-9,029 Reduced 15.93%
47,640 $118,000
Q1 2022

May 16, 2022

BUY
$3.28 - $7.12 $85,152 - $184,842
25,961 Added 84.54%
56,669 $217,000
Q4 2021

Feb 14, 2022

BUY
$6.55 - $13.25 $108,487 - $219,459
16,563 Added 117.09%
30,708 $205,000
Q3 2021

Nov 15, 2021

BUY
$7.29 - $11.0 $88,537 - $133,595
12,145 Added 607.25%
14,145 $128,000
Q2 2021

Aug 13, 2021

BUY
$9.87 - $13.32 $19,740 - $26,640
2,000 New
2,000 $23,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $823M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.